{
    "code": "06024522",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06024522",
    "time": "2018-03-09 03:34:40",
    "許可證字號": "衛署醫器輸字第024522號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/01\/18",
    "發證日期": "102\/01\/18",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第三等級",
    "通關簽審文件編號": "DHA00602452209",
    "中文品名": "羅氏EGFR基因突變檢驗套組",
    "英文品名": "cobas EGFR Mutation Test",
    "效能": "本產品為一即時PCR檢測，針對以福馬林固定石蠟包埋(FFPET)的人類非小細胞肺癌(human non-small cell lung cancer (NSCLC))腫瘤組織之DNA中上皮生長因子接受體(epidermal growth factor receptor (EGFR))基因exon 18、19、20和21的突變進行定性偵測及鑑別。此項試驗是設計來確認末期人類非小細胞肺癌患者其腫瘤帶有EGFR基因exon 18、19、20和21突變，並選擇出可以小分子酪胺酸激&#37238;抑制劑(tyrosine kinase inhibitors (TKIs))治療的病人，因為抑制劑的標的為EGFR。使用羅氏去氧核醣核酸萃取試劑套組(cobas DNA Sample Preparation Kit)手工處理檢體，然後在cobas z 480分析儀上進行自動化的放大反應和結果偵測。",
    "醫器規格": "cobas EGFR Mutation Test (P\/N: 06471463190),以下空白",
    "劑型": "",
    "包裝": "",
    "標籤、仿單及包裝加註": "",
    "": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器次類別一": "B4020分析特定試劑",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "主成分略述": [
        ""
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1903101100  台灣羅氏醫療診斷設備股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "M461033100  ROCHE MOLECULAR SYSTEMS, INC.",
        "製造廠廠址": "1080 US HIGHWAY 202 SOUTH BRANCHBURG, NJ-08876, USA",
        "製造廠公司地址": "",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060245220003___20130322.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06024522&Seq=001&Type=9"
        },
        {
            "title": "060245220001___20130322.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06024522&Seq=001&Type=8"
        }
    ]
}